| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 10/02/1997 | CA2250241A1 Arylamino fused pyridines and pyrimidines |
| 10/02/1997 | CA2250187A1 Composition comprising olanzapine and a drug useful in the treatment of pain for use in the treatment of pain |
| 10/02/1997 | CA2250042A1 Treating pain using a synergistic combination of an atypical antipsychotic and a drug used in treatment of pain |
| 10/02/1997 | CA2249985A1 Tumour necrosis factor alpha convertase |
| 10/02/1997 | CA2248675A1 Cyclic nucleotide phosphodiesterase |
| 10/01/1997 | EP0797593A2 Improved cyclic crf antagonists |
| 10/01/1997 | EP0797583A1 Tachykinin antagonists |
| 10/01/1997 | EP0797442A1 Treatment of optic neuritis |
| 10/01/1997 | EP0797435A1 Controlled release matrix for pharmaceuticals |
| 10/01/1997 | EP0797427A1 Agents acting against hyperreactive and hypoactive, deficient skin conditions and manifest dermatitides |
| 10/01/1997 | CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist |
| 10/01/1997 | CN1161041A Heterocycle-condensed morphinoid derivatives |
| 10/01/1997 | CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 09/30/1997 | US5672705 Antiischemic agents treating nervous system disorders, huntington' disease, alzheimer's disease, parkinson's disease |
| 09/30/1997 | US5672620 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 09/30/1997 | US5672618 Protein kinase C inhibitors |
| 09/30/1997 | US5672613 2-(4-methoxyphenoxy)-3-pyridineamine, its pharmaceutical compositions and therapeutic use |
| 09/30/1997 | US5672602 Substituted piperazine derivatives |
| 09/30/1997 | US5672598 Matrix metalloprotease inhibitors |
| 09/30/1997 | US5672583 Carboxy-peptidyl derivatives as antidegenerative active agents |
| 09/29/1997 | CA2200267A1 Novel sphingolipids and a process thereto |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997035006A1 Human cell death-associated protein |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034893A1 Pharmaceutically useful compounds |
| 09/25/1997 | WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action |
| 09/25/1997 | WO1997034882A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
| 09/25/1997 | WO1997034874A1 1,3,5-trisubstituted indazole derivatives with an anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating action |
| 09/25/1997 | WO1997034600A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 09/25/1997 | WO1997034565A2 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | DE19610955A1 Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid Combination preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl) - anilide and N- (4-trifluoromethylphenyl) -2-cyano-3- hydroxycrotonamide |
| 09/25/1997 | DE19610882A1 Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 1,3,5-tri-substituted indazole derivatives having anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect, processes for their preparation and their use as medicaments |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249420A1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248614A1 Human cell death-associated protein |
| 09/25/1997 | CA2248092A1 Harpagoside-enriched extract from harpagophytum procumbens and processes for producing same |
| 09/25/1997 | CA2247814A1 Pharmaceutically useful compounds |
| 09/24/1997 | EP0796866A1 Antithrombotic diamides |
| 09/24/1997 | EP0796861A1 Silated derivatives of salicilic acid with desquamative properties |
| 09/24/1997 | EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists |
| 09/24/1997 | EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation |
| 09/24/1997 | EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases |
| 09/24/1997 | EP0796260A1 Rapamycin 42-oximes and hydroxylamines |
| 09/24/1997 | EP0796257A1 Malonic acid based matrix metalloproteinase inhibitors |
| 09/24/1997 | EP0796109A1 Antisense oligonucleotides to suppress eicosanoid formation |
| 09/24/1997 | EP0796100A1 Combined use of diclofenac and tribenoside to treat osteoarthritis |
| 09/24/1997 | EP0796093A1 Compounds for and method of inhibiting phosphodiesterase iv |
| 09/24/1997 | EP0796092A1 3,3-(disubstituted)cyclohexan-1-one dimers and related compounds |
| 09/24/1997 | EP0796091A1 3,3-(disubstituted)cyclohexan-1-ol monomers and related compounds |
| 09/24/1997 | EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
| 09/24/1997 | EP0673245B1 Effervescent pharmaceutical composition containing ibuprofen and method for preparing same |
| 09/24/1997 | EP0636143B1 Alpha-aminoboronic acid peptides and their use as elastase inhibitors |
| 09/24/1997 | CN1160402A Purine and guanine compounds as inhibitors of PNP |
| 09/24/1997 | CN1160399A Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4) antagonists |
| 09/24/1997 | CN1160398A Compositions and methods for treating mast-cell inflammatory condition |
| 09/24/1997 | CN1160356A Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 09/24/1997 | CN1160352A Diazepino-indoles as phosphodiesterase IV inhibitors |
| 09/24/1997 | CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular. |
| 09/24/1997 | CN1160045A Matrix metalloprotease inhibitors |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1159949A Use of peptide compounds and pharmaceutically acceptable salts thereof for manufacturing medicament for treating diseases |
| 09/24/1997 | CN1159931A Anti-inflammatory and analgesic capsule |
| 09/24/1997 | CN1035944C Method for preparing 3-aminopiperidine derivs. and related nitrogen-contg. heterocycles |
| 09/23/1997 | US5670695 Process for the preparation of diacerein |
| 09/23/1997 | US5670684 Process and intermediates for the preparation of excitatory amino acid receptor antagonists |
| 09/23/1997 | US5670546 N-Arylalkylphenylacetamide derivatives |
| 09/23/1997 | US5670540 Triglycerides of fatty acids |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670524 Methods and compositions for the treatment of pain utilizing ropivacaine |
| 09/23/1997 | US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670499 Physiological disorders, gastrointestinal disorders, antiinflammatory agents |
| 09/23/1997 | US5670494 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 09/23/1997 | CA2045857C Diaminotrifluoromethylpyridine derivatives, process for their production and phospholipase a2 inhibitor containing them |
| 09/22/1997 | CA2200163A1 Antithrombotic diamides |
| 09/20/1997 | CA2200385A1 1,3,5-trisubstituted indazole derivatives, processes for preparing, and for pharmacological treatment therewith |
| 09/20/1997 | CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034002A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033902A1 Human tumor necrosis factor delta and epsilon |
| 09/18/1997 | WO1997033887A1 Spirocycle integrin inhibitors |
| 09/18/1997 | WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases |
| 09/18/1997 | WO1997033856A1 Diaromatic propynyl or dienyl compounds |
| 09/18/1997 | WO1997033603A1 Novel peptides which inhibit complement activation |
| 09/18/1997 | WO1997026866A3 Preparations of non-steroidal analgesics |
| 09/18/1997 | WO1997025351A3 INHIBITORS OF MAdCAM-1-MEDIATED INTERACTIONS AND METHODS OF USE THEREFOR |
| 09/18/1997 | DE19610357A1 Geminale Difluorderivate von Phenylacetamid und Phenylessigsäure, Verfahren zu deren Herstellung sowie deren pharmazeutische Zusammensetzungen Geminal difluoro of phenylacetamide and phenylacetic acid, a process for their preparation and their pharmaceutical compositions |
| 09/18/1997 | CA2249733A1 Spirocycle integrin inhibitors |
| 09/18/1997 | CA2247888A1 Human bikunin |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/17/1997 | EP0795334A2 Prodrugs for the treatment tumors and inflammatory diseases |
| 09/17/1997 | EP0794966A1 Humanized antibodies to cd38 |
| 09/17/1997 | EP0794956A1 Substituted 2-(phosphinyloxymethyl)-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof |